ative therapy depending on the identified symptoms.
Clarotadine is a drug from the group of H1-histamine receptor blockers that is used to treat various allergic reactions. Its active ingredient, loratadine, is a selective antagonist of histamine H1 receptors, blocking their effect on the body. Clarotadine is available in the form of 10 mg tablets and 5 mg/5 ml syrup.
Clarotadine is recommended for the treatment of allergic rhinitis (year-round and seasonal), hay fever, allergic conjunctivitis, chronic idiopathic urticaria, as well as for the treatment of itchy dermatoses associated with allergic reactions to insect bites and other causes. Clarotadine can also be used as an adjuvant for bronchial asthma.
Contraindications to the use of Clarotadine are hypersensitivity to its components, lactation and children under 2 years of age. Use during pregnancy is only possible if the expected benefit to the mother outweighs the potential risk to the fetus and newborn.
When using Clarotadine, side effects may occur, such as headache, drowsiness, fatigue, difficulty concentrating, dizziness, nervousness, anxiety, agitation (in children), insomnia, fainting, amnesia, depression, hyperkinesia, tremor, paresthesia, hypoesthesia, dysphonia , visual impairment, changes in lacrimation, conjunctivitis, blepharospasm, pain in the eyes and ears, tinnitus, dry mouth, increased appetite, weight gain, anorexia, nausea, changes in salivation, taste disturbance, toothache, stomatitis, vomiting, gastritis , flatulence, dyspepsia, constipation or diarrhea. Very rare but possible side effects of Clarotadine may include jaundice, hepatitis, liver necrosis, anaphylaxis, alopecia, increased breast size, erythema multiforme and others.
When taking Clarotadine concomitantly with erythromycin, ketoconazole or cimetidine, an increase in the concentration of loratadine and its active metabolite in the blood may be observed. In this case, the level of erythromycin in plasma may decrease.
In case of an overdose of Clarotadine, symptoms such as dizziness, drowsiness and fatigue may occur. In more severe cases, serious cardiovascular and nervous system problems may occur, such as cardiac arrhythmias, seizures, hypotension, ataxia, and coma. In case of overdose, seek medical help immediately.
Clarotadine should be taken in accordance with the instructions for use and only as prescribed by a doctor. The dosage and duration of treatment are determined individually depending on the patient’s age, weight, health status and disease characteristics. It is not recommended to exceed the dosage specified in the instructions for use.
In general, Clarotadine is an effective and safe drug when used correctly and following your doctor's recommendations. However, before starting treatment, it is necessary to consult with a specialist to eliminate possible contraindications and risks of side effects.